CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative

CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedica...

Descripción completa

Detalles Bibliográficos
Autores: Luque, Juan, Mendes, Ingrid, Gómez, Beatriz, Morte, Beatriz, López de Heredia, Miguel de, Herreras, Enrique, Corrochano, Virginia, Bueren, Juan, Gallano, Pía, Artuch, Rafael, Fillat i Fonts, Cristina, Pérez Jurado, Luis Alberto, Montoliu, Lluis, Carracedo, Ángel, Millán, José M., Webb, Susan M., Palau, Francesc, CIBERER Network, Lapunzina, Pablo Daniel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/53514
Acceso en línea:http://hdl.handle.net/10230/53514
http://dx.doi.org/10.1111/cge.14113
Access Level:acceso abierto
Palabra clave:Genetics
New therapeutic approaches
Novel genes
Rare diseases
Research network
id ES_a0da95fb5135592526e78ea7300a5730
oai_identifier_str oai:recercat.cat:10230/53514
network_acronym_str ES
network_name_str España
repository_id_str
spelling CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiativeLuque, JuanMendes, IngridGómez, BeatrizMorte, BeatrizLópez de Heredia, Miguel deHerreras, EnriqueCorrochano, VirginiaBueren, JuanGallano, PíaArtuch, RafaelFillat i Fonts, CristinaPérez Jurado, Luis AlbertoMontoliu, LluisCarracedo, ÁngelMillán, José M.Webb, Susan M.Palau, FrancescCIBERER NetworkLapunzina, Pablo DanielGeneticsNew therapeutic approachesNovel genesRare diseasesResearch networkCIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research.Wiley202220222022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/53514http://dx.doi.org/10.1111/cge.14113reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésClin Genet. 2022 May;101(5-6):481-93© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:10230/535142026-05-29T05:05:01Z
dc.title.none.fl_str_mv CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
title CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
spellingShingle CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
Luque, Juan
Genetics
New therapeutic approaches
Novel genes
Rare diseases
Research network
title_short CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
title_full CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
title_fullStr CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
title_full_unstemmed CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
title_sort CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative
dc.creator.none.fl_str_mv Luque, Juan
Mendes, Ingrid
Gómez, Beatriz
Morte, Beatriz
López de Heredia, Miguel de
Herreras, Enrique
Corrochano, Virginia
Bueren, Juan
Gallano, Pía
Artuch, Rafael
Fillat i Fonts, Cristina
Pérez Jurado, Luis Alberto
Montoliu, Lluis
Carracedo, Ángel
Millán, José M.
Webb, Susan M.
Palau, Francesc
CIBERER Network
Lapunzina, Pablo Daniel
author Luque, Juan
author_facet Luque, Juan
Mendes, Ingrid
Gómez, Beatriz
Morte, Beatriz
López de Heredia, Miguel de
Herreras, Enrique
Corrochano, Virginia
Bueren, Juan
Gallano, Pía
Artuch, Rafael
Fillat i Fonts, Cristina
Pérez Jurado, Luis Alberto
Montoliu, Lluis
Carracedo, Ángel
Millán, José M.
Webb, Susan M.
Palau, Francesc
CIBERER Network
Lapunzina, Pablo Daniel
author_role author
author2 Mendes, Ingrid
Gómez, Beatriz
Morte, Beatriz
López de Heredia, Miguel de
Herreras, Enrique
Corrochano, Virginia
Bueren, Juan
Gallano, Pía
Artuch, Rafael
Fillat i Fonts, Cristina
Pérez Jurado, Luis Alberto
Montoliu, Lluis
Carracedo, Ángel
Millán, José M.
Webb, Susan M.
Palau, Francesc
CIBERER Network
Lapunzina, Pablo Daniel
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Genetics
New therapeutic approaches
Novel genes
Rare diseases
Research network
topic Genetics
New therapeutic approaches
Novel genes
Rare diseases
Research network
description CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022
2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/53514
http://dx.doi.org/10.1111/cge.14113
url http://hdl.handle.net/10230/53514
http://dx.doi.org/10.1111/cge.14113
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Clin Genet. 2022 May;101(5-6):481-93
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869415062912892928
score 15,811543